Skip to content

Price / sales at other companies

AngioDynamics logo
AngioDynamicsANGO
1.5×+0.2×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.7×-1.8×
Solventum logo
SolventumSOLV
1.4×-0.2×
MiMedx Group logo
MiMedx GroupMDXG
1.5×-1.7×
United Therapeutics logo
United TherapeuticsUTHR
8.2×+3.6×
Theravance Biopharma logo
Theravance BiopharmaTBPH
7.6×+0.8×

Other financials

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Cash & equivalents$75.0M-10.3%
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation

See full
Market cap$631.58M+172%
Enterprise value$571.76M+203%
P/E31.1×+16.8×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Where this comes from

Calculated from Tactile Systems Technology’s reported figures.

Based on the most recent quarter.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tactile Systems Technology's price / sales?
Tactile Systems Technology (TCMD) reported price / sales of 1.7× in Q1 2026.
How has Tactile Systems Technology's price / sales changed year-over-year?
Tactile Systems Technology's price / sales increased by 62.2% year-over-year, from 1.1× to 1.7×.
What is the long-term trend for Tactile Systems Technology's price / sales?
Over 5 years (2020 to 2025), Tactile Systems Technology's price / sales has grown at a -16.2% compound annual growth rate (CAGR), from 4.8× to 2×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.